FundingWatcher
Home / Startups / By venture fund / ARCH Venture Partners portfolio companies

ARCH Venture Partners portfolio companies

Updated 16 Nov 2026

http://www.archventure.com

ARCH Venture Partners portfolio companies
One-time CSV
  • 38 funded companies, 35 with a website
  • Last round, amount, date, total raised and investors
  • CRM-ready CSV, 18 columns
  • Download right after payment
With founder contacts
Compiled to order
  • The full startup CSV, plus founders and executives
  • Up to 2 founders or CEOs per company, compiled to order
  • Name, job title and LinkedIn URL where found
  • Verified direct email per person
  • Startup CSV at once, contacts CSV by mail within 24 hours
Download right after paymentFree 10-row sampleSecure checkout by Stripe

Not sure about the data?

Download a free 10-row sample first. No account, no payment.

startups-investor-arch-venture-partners.csv38 rows × 18 columns
CompanyCityLast roundAmountDate
Moonwalk BiosciencesSouth San FranciscoSeries B$70.0M2026-09-08
Xaira TherapeuticsSouth San FranciscoSeries A$1.0B2024-04-23
Quantum CircuitsNew HavenSeries B$60.0M2024-05-01
InsitroSouth San FranciscoSeries C$400.0M2021-03-15
Pioneer Square LabsSeattleSeries B$15.0M2018-01-18
MoleculentSolnaSeries A$20.0M2026-04-30
AIRNACambridgeSeries B$155.0M2025-04-01
Mirador TherapeuticsSan DiegoSeries B$250.0M2026-01-12

8 rows of the CSV in 5 of its 18 columns.

38
Startups
$6.2B
Total raised
3
Funded in the last 12 months
$340.0M
Raised in the last 12 months

Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.

Newest rounds

17 of 38
17 rows
Company What they do Sector Location Last round Amount Date Total raised Investors Employees Founded
Moonwalk Biosciences Moonwalk Biosciences develops precision epigenetic medications through its genomic medicine platform. Artificial intelligence South San Francisco, United States Series B $70.0M 2026-09-08 $127.0M Google Ventures, Khosla Ventures, ARCH Venture Partners +2 11 to 50 2022
Moleculent Moleculent is a biotechnology research company. Biotech Solna, Sweden Series A $20.0M 2026-04-30 $46.0M ARCH Venture Partners, EIR Ventures 11 to 50 2021
Mirador Therapeutics Mirador Therapeutics develops precision medicines for immune-mediated diseases. Biotech San Diego, United States Series B $250.0M 2026-01-12 $730.0M OrbiMed, Fidelity, ARCH Venture Partners +1 11 to 50 2024
Gate Bioscience Gate Bioscience is a biotechnology company developing small molecule treatments for hard-to-treat diseases. Biotech Brisbane, United States Series B $65.0M 2025-11-13 $125.0M Andreessen Horowitz, Google Ventures, ARCH Venture Partners +1 11 to 50 2021
Synchron Synchron develops neuromodulation solutions for nervous system conditions previously untreatable. Health care Brooklyn, United States Series D $200.0M 2025-11-06 $330.0M Alumni Ventures, Khosla Ventures, ARCH Venture Partners +1 101 to 250 2016
AIRNA AIRNA develops RNA editing technologies to create medicines for various diseases. Biotech Cambridge, United States Series B $155.0M 2025-04-01 $245.0M ARCH Venture Partners, Alexandria Venture Investments, Forbion Capital Partners +2 51 to 100 2021
Rhygaze Rhygaze develops a gene therapy that targets cone cells to restore vision in blinding diseases. Biotech Basel, Switzerland Series A $86.0M 2025-01-10 $97.3M Google Ventures, F-Prime, ARCH Venture Partners +2 11 to 50 2024
ArsenalBio ArsenalBio develops programmable CAR T-cell therapies for solid tumors. Biotech South San Francisco, United States Series C $325.0M 2024-09-04 $630.8M ARCH Venture Partners, Bristol-Myers Squibb, NVentures +1 251 to 500 2019
Quantum Circuits Quantum Circuits is building a full-stack quantum computer based on dual-rail qubits. Hardware New Haven, United States Series B $60.0M 2024-05-01 $78.0M Sequoia Capital, F-Prime, IQT +2 51 to 100 2015
Xaira Therapeutics Unicorn Xaira Therapeutics applies artificial intelligence to drug discovery and biotechnology research. Artificial intelligence South San Francisco, United States Series A $1.0B 2024-04-23 $1.0B Sequoia Capital, New Enterprise Associates, Menlo Ventures +2 101 to 250 2023
Matter Neuroscience Matter Neuroscience studies the brain's reward systems to develop treatments for mental health conditions. Health care Boulder, United States Seed $26.0M 2024-02-27 $26.0M Polaris Partners, Collaborative Fund, ARCH Venture Partners 11 to 50 2019
Accompany Health Accompany Health delivers in-home care to patients in underserved regions. Health care Bethesda, United States Series A $56.0M 2024-01-30 $56.0M Venrock, IVP, ARCH Venture Partners +2 101 to 250 2022
Basking Biosciences Basking Biosciences commercializes technologies developed at Duke University and Ohio State University. Biotech Durham, United States Series A $55.0M 2024-01-30 $62.3M Insight Partners, Rev1 Ventures, ARCH Venture Partners +1 1 to 10 2019
HI-Bio HI-Bio develops therapies for immune-mediated diseases. Biotech South San Francisco, United States Series B $95.0M 2024-01-04 $215.0M ARCH Venture Partners, Alpha Wave Global, Viking Global Investors +1 101 to 250 2021
Insitro Unicorn Insitro applies machine learning and biology to drug discovery and development. Artificial intelligence South San Francisco, United States Series C $400.0M 2021-03-15 $643.0M Temasek, BlackRock, ARCH Venture Partners +1 251 to 500 2018
Aira Aira provides tech-enabled services for visually impaired people worldwide. Hardware La Jolla, United States Series B $20.0M 2018-12-21 $35.6M National Science Foundation, Felicis, Lux Capital +1 51 to 100 2014
Pioneer Square Labs Pioneer Square Labs is a studio that creates and launches technology startups. Fintech Seattle, United States Series B $15.0M 2018-01-18 $27.5M Techstars, Menlo Ventures, True Ventures +1 11 to 50 2015

Table 1. ARCH Venture Partners portfolio companies: the 17 newest rounds whose row carries a description, a city, a named fund and an amount. Source: FundingWatcher. Data as of 16 November 2026. Base: 38.

Largest rounds

Last 12 months
# Company What they do Sector Location Last round Amount Date Total raised Investors Employees Founded
1 Mirador Therapeutics Mirador Therapeutics develops precision medicines for immune-mediated diseases. Biotech San Diego, United States Series B $250.0M 2026-01-12 $730.0M OrbiMed, Fidelity, ARCH Venture Partners +1 11 to 50 2024
2 Moonwalk Biosciences Moonwalk Biosciences develops precision epigenetic medications through its genomic medicine platform. Artificial intelligence South San Francisco, United States Series B $70.0M 2026-09-08 $127.0M Google Ventures, Khosla Ventures, ARCH Venture Partners +2 11 to 50 2022
3 Moleculent Moleculent is a biotechnology research company. Biotech Solna, Sweden Series A $20.0M 2026-04-30 $46.0M ARCH Venture Partners, EIR Ventures 11 to 50 2021

Table 2. ARCH Venture Partners portfolio companies: the 3 largest rounds of the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Most active investors

By companies backed
#InvestorTypeLocation CompaniesShare Funded, 12 monthsLatest
1 Google Ventures Corporate venture arm San Francisco, United States 5 13% 1 Moonwalk Biosciences
2 F-Prime Venture capital firm Cambridge, United States 5 13%
3 Polaris Partners Private equity firm Boston, United States 4 11%
4 Sequoia Capital Venture capital firm Menlo Park, United States 3 8%
5 Menlo Ventures Venture capital firm Menlo Park, United States 3 8%
6 Alexandria Venture Investments Venture capital firm Pasadena, United States 3 8%
7 Madrona Venture capital firm Seattle, United States 3 8%
8 Khosla Ventures Venture capital firm Menlo Park, United States 2 5% 1 Moonwalk Biosciences
9 Alpha Wave Global Private equity firm Miami, United States 2 5% 1 Moonwalk Biosciences
10 Temasek Private equity firm Singapore 2 5%
11 NVentures Corporate venture arm Santa Clara, United States 2 5%
12 Alumni Ventures Angel group Manchester, United States 2 5%
13 Future Ventures Venture capital firm San Francisco, United States 1 3% 1 Moonwalk Biosciences
14 New Enterprise Associates Venture capital firm Menlo Park, United States 1 3%
15 Connecticut Innovations Government investment office Rocky Hill, United States 1 3%

Table 3. ARCH Venture Partners portfolio companies: the funds recorded as investors in the most companies. Latest: companies they back that raised in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Sectors

SectorsCompaniesShareTotal raised
Health care 25 66% $5.7B
Biotech 22 58% $5.4B
Software 19 50% $3.4B
Artificial intelligence 6 16% $2.4B
Hardware 5 13% $291.9M
Fintech 2 5% $75.8M
Commerce 1 3% $18.0M
Cybersecurity 1 3%

Table 4. ARCH Venture Partners portfolio companies by sector. Source: FundingWatcher. Data as of 16 November 2026.

Funding stage

Funding stageCompaniesShareMedian last round
Pre-seed 1 3%
Seed 2 5% $26.0M
Series A 12 32% $55.0M
Series B 15 39% $60.0M
Series C 6 16% $200.0M
Series D+ 2 5% $200.0M

Table 5. ARCH Venture Partners portfolio companies by stage of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.

Countries

CountriesCompaniesShare
United States 36 95%
Sweden 1 3%
Switzerland 1 3%

Table 6. ARCH Venture Partners portfolio companies by headquarters country. Source: FundingWatcher. Data as of 16 November 2026.

Cities

CitiesCompaniesShare
South San Francisco 5 13%
Seattle 4 11%
Cambridge 4 11%
Brisbane 2 5%
San Francisco 2 5%
Boulder 2 5%
New Haven 1 3%
Solna 1 3%
San Diego 1 3%
Bethesda 1 3%
Brooklyn 1 3%
La Jolla 1 3%

Table 7. ARCH Venture Partners portfolio companies by headquarters city. Source: FundingWatcher. Data as of 16 November 2026.

Rounds by month

Rounds by monthCompaniesShareRaised
September 2026 1 33% $70.0M
April 2026 1 33% $20.0M
January 2026 1 33% $250.0M

Table 8. ARCH Venture Partners portfolio companies: most recent round by month, last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Most recent round by year

Most recent round by yearCompaniesShareRaised
2026 3 8% $340.0M
2025 5 13% $706.0M
2024 11 29% $1.7B
2023 3 8% $50.0M
2022 1 3% $45.0M
2021 1 3% $400.0M

Table 9. ARCH Venture Partners portfolio companies by year of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.

Founding year

Founding yearCompaniesShare
2023 or later 6 16%
2020 to 2022 11 29%
2015 to 2019 10 26%
2010 to 2014 3 8%
Before 2010 8 21%

Table 10. ARCH Venture Partners portfolio companies by founding year. Source: FundingWatcher. Data as of 16 November 2026.

Team size

Team sizeCompaniesShare
1 to 10 7 19%
11 to 50 18 49%
51 to 100 4 11%
101 to 250 6 16%
251 to 500 2 5%

Table 11. ARCH Venture Partners portfolio companies by headcount. Source: FundingWatcher. Data as of 16 November 2026.

Method

Sources, fields and exclusions of both files: Method.

Questions

How many ARCH Venture Partners portfolio companies are on the list?
38, in the file dated 16 November 2026. 3 of them closed their most recent round in the last 12 months.
What does the CSV contain?
One row per company, 18 columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.
How much does the list cost?
$29 one-time for all 38 rows, no account. Every investor and every startup, two files, cost $99. With founder contacts, up to 2 founders or CEOs per company compiled to order and mailed within 24 hours, $199.
What arrives after payment?
At once: the CSV download link, on the page after payment and by mail.
Can I see rows before buying?
The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
How current is the data?
The file is dated 16 November 2026. The download link serves the current file each time it is opened.

ARCH Venture Partners portfolio companies: 38 rows, CSV, $29 one-time.

At once: the CSV download link, on the page after payment and by mail.

Columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.

With founder contacts: $199 one-time. List CSV right after payment; up to 2 verified founder or CEO emails per company compiled to order within 24 hours.

Not sure about the data?

Download a free 10-row sample first. No account, no payment.

Portfolio companies by country

Portfolio companies by city

Other venture fund portfolios

Cite: FundingWatcher, 38 startups, 16 November 2026. https://fundingwatcher.com/startups/investor/arch-venture-partners/